Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-1998 | 12-1997 | 09-1997 | 06-1997 | |
Sales | 109 | 149 | 104 | 225 |
Gross Profit | 110 | 149 | 100 | 225 |
Operating Expenses | 690 | 0 | 450 | 0 |
Operating Income | -581 | 149 | -346 | 225 |
Interest Expense | 0 | 0 | 10 | 0 |
Other Income | 91 | 0 | -14 | 0 |
Pre-tax Income | -490 | 149 | -370 | 225 |
Net Income Continuous | -493 | -432 | -377 | -244 |
Net Income | $-493 | $-432 | $-377 | $-244 |
EPS Basic Total Ops | -0.32 | -0.40 | -0.44 | -0.24 |
EPS Basic Continuous Ops | -0.34 | -0.38 | -0.45 | -0.23 |
EPS Diluted Total Ops | -0.32 | -0.40 | -0.44 | -0.24 |
EPS Diluted Continuous Ops | -0.34 | -0.38 | -0.45 | -0.23 |
EBITDA(a) | $-521 | $199 | $-346 | $225 |